The effect of mindfulness meditation on sleep quality and negative emotions in stroke patients with heart disease

Not Applicable

Completed

Conditions: Sleep quality and negative emotions in stroke patients with concurrent coronary heart disease
Mental and Behavioural Disorders

Registration Number: ISRCTN15770131

Lead Sponsor: Second Hospital of Hebei Medical University

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 72

Inclusion Criteria

1. First onset of ischemic stroke confirmed via imaging, with a prior clear diagnosis of concurrent coronary heart disease
2. Presence of insomnia that appeared either after the stroke or within one month before the stroke onset, with a Pittsburgh Sleep Quality Index (PSQI) score of = 7
3. Self-Rating Anxiety Scale (SAS) score of = 50 and Self-Rating Depression Scale (SDS) score of = 53
4. Clear consciousness, normal cognitive function, and ability to cooperate with treatment
5. Voluntary signing of informed consent by the patient and their family for participation in this trial

Exclusion Criteria

1. Aphasia, abnormal mental behavior post-AIS, or severe consciousness disorders
2. Existence of unstable angina or myocardial infarction within the past two weeks
3. Significant organ dysfunction
4. Patients with malignant tumors
5. Existence of sleep disorders for more than one month before the stroke onset, or sleep disorders caused by medications or other systemic diseases
6. History of allergy to eszopiclone or similar medications

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The following primary outcome measures will be assessed before the intervention, and/or after 6 and 12 weeks of the intervention:<br>1. Sleep quality measured using the Pittsburgh Sleep Quality Index (PSQI)<br>2. Anxiety measured using the Self-Rating Anxiety Scale (SAS) <br>3. Depression measured using Self-Rating Depression Scale (SDS)<br>4. Motor function measured using the Fugl-Meyer Assessment (FMA)

Secondary Outcome Measures